NASDAQ
Daxor Corporation - Closed End Fund (DXR)
♥ 310 Thanks from members
Daxor Corporation (DXR) exhibits neutral-to-cautious market sentiment as it navigates a transition out of closed-end fund status alongside a registered direct stock offering, featuring steady clinical product interest for its FDA-cleared blood volume analyzer and low trading liquidity.